Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TRC210258
Cat. No.:
OB0425LY-058
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
TRC210258 is a novel small molecule compound used to modulate specific biological pathways.
Synonyms:
trc210258; 1431553-15-9; N-(4-Chlorophenyl)-2-(4-fluorophenoxy)-N-methylimidazo (1, 2-a) pyrimidine-3-carboxamide; N-(4-Chlorophenyl)-2-(4-fluorophenoxy)-N-methylimidazo[1,2-a]pyrimidine-3-carboxamide
CAS No.:
1431553-15-9
Compound CID:
71554157
Formula:
C20H14ClFN4O2
Formula Weight:
396.8
Specification
Target:
Endogenous metabolite
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
TRC210258 can be used to improve diabetes-related hyperglycemia and dyslipidemia.
